Combinations containing amoxicillin-clavulanate and tetracycline are inappropriate for Helicobacter pylori eradication despite high in vitro susceptibility (Q80157924)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 October 2006

Language	Label	Description	Also known as
English	Combinations containing amoxicillin-clavulanate and tetracycline are inappropriate for Helicobacter pylori eradication despite high in vitro susceptibility	scientific article published on 01 October 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16928222%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Combinations containing amoxicillin-clavulanate and tetracycline are inappropriate for Helicobacter pylori eradication despite high in vitro susceptibility (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16928222%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Helicobacter pylori

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16928222%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

7

object named as

Hyun Chae Jung

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16928222%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

3

object named as

Jung Mogg Kim

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16928222%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Sang Gyun Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16928222%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Nayoung Kim

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16928222%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Dong Ho Lee

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16928222%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Joo Sung Kim

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16928222%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

In Sung Song

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16928222%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 October 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16928222%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Journal of Gastroenterology and Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16928222%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16928222%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16928222%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1590-1595

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16928222%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Helicobacter pyloriInfection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04291.X

21 January 2018

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04291.X

21 January 2018

Evaluation of treatment regimens to cure Helicobacter pylori infection--a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04291.X

21 January 2018

Helicobacter pylori therapy: first-line options and rescue regimen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04291.X

21 January 2018

Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection: a 24-month follow-up study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04291.X

21 January 2018

A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04291.X

21 January 2018

Eradication of Helicobacter pylori: an objective assessment of current therapies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04291.X

21 January 2018

Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04291.X

21 January 2018

Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04291.X

21 January 2018

Antimicrobial susceptibility of Helicobacter pylori strains isolated in Bangladesh

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04291.X

21 January 2018

Universal high-level primary metronidazole resistance in Helicobacter pylori isolated from children in Egypt

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04291.X

21 January 2018

Resistance of Helicobacter pylori isolated in Israel to metronidazole, clarithromycin, tetracycline, amoxicillin and cefixime

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04291.X

21 January 2018

Quadruple therapy containing amoxicillin and tetracycline is an effective regimen to rescue failed triple therapy by overcoming the antimicrobial resistance of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04291.X

21 January 2018

Antibacterial activities of beta-lactamase inhibitors associated with morphological changes of cell wall in Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04291.X

21 January 2018

Beta-lactamase inhibitor enhances Helicobacter pylori eradication rate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04291.X

21 January 2018

Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04291.X

21 January 2018

Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04291.X

21 January 2018

A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04291.X

21 January 2018

Amoxicillin/tetracycline combinations are inadequate as alternative therapies for Helicobacter pylori infection.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04291.X

21 January 2018

Third line treatment for Helicobacter pylori: a prospective, culture-guided study in peptic ulcer patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04291.X

21 January 2018

High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04291.X

21 January 2018

Second‐line treatment for failure to eradicate Helicobacter pylori: a randomized trial comparing four treatment strategies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04291.X

21 January 2018

First-line eradication therapy for Helicobacter pylori in primary health care based on antibiotic resistance: results of three eradication regimens

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04291.X

21 January 2018

Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second-line Helicobacter pylori eradication in Japan, and the influence of metronidazole resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04291.X

21 January 2018

Identifiers

10.1111/J.1440-1746.2006.04291.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16928222%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16928222%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80157924&oldid=1814505305"